TABLE 1.
Clinical characteristics of HIV-1-infected donor groups
| HAART group | No. of subjects | Median age (range) (yr) | Median T-cell count (range) (cells/mm3) | Median T-cell count at nadir (range) (cells/mm3) | Median no. of copies of HIV mRNA/ml of plasma (range) |
|---|---|---|---|---|---|
| Suppresseda | 13 | 42 (31-48) | 461 (130-947) | 225 (0-581) | 20 (20-346) |
| Failureb | 9 | 40 (32-47) | 141 (48-500) | 64 (0-267) | 11,166 (4,469-1.61 × 106) |
| Naive | 10 | 32 (28-54) | 397 (97-1,055) | 174 (9-800) | 20,230 (1,985-1.07 × 106) |
Viral load, <400 copies of HIV-1 RNA/ml of plasma for ≥4 months.
Viral load, >1,000 copies of HIV-1 RNA/ml of plasma for ≥4 months.